Literature DB >> 9754620

No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families.

M Neves-Pereira1, A S Bassett, W G Honer, D Lang, N A King, J L Kennedy.   

Abstract

Schizophrenia patients demonstrate a deficiency in the filtering of sensory information, and one specific measure involves a response to the second of a pair of auditory stimuli. A neurophysiological measure of this consists of the electroencephalographic response to pairs of auditory signals, emitted fractions of a second apart. Schizophrenic patients and some of their unaffected relatives show a failure of inhibition of a second tone if it occurs 50 msec after the first. A recent genome scan indicated that the gating defect is linked to the alpha 7 neuronal nicotinic acetyl choline receptor gene on chromosome 15. We genotyped 5 schizophrenia families with a total of 96 subjects with a dinucleotide polymorphic marker located less than 120 kb from the first exon of the alpha 7 neuronal nicotinic acetylcholine receptor gene. Linkage analysis was undertaken using parametric and nonparametric statistical methods. The results of the parametric analysis showed negative lod scores under both narrow and broad diagnosis (lod = -3.6 and -4.8, respectively, at theta = 0), and dominant and recessive modes of transmission of the disease. Nonparametric analysis using GENEHUNTER produced nonsignificant NPL scores (NPL = -0.4 and -0.3 for broad and narrow diagnoses, respectively). In summary, we did not find any evidence that the alpha 7 neuronal nicotinic acetylcholine receptor gene (CHRNA7) is linked to schizophrenia. However, we have not been able to assess the P50 measures in these families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754620      PMCID: PMC3169643          DOI: 10.1002/(sici)1096-8628(19980907)81:5<361::aid-ajmg3>3.0.co;2-w

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Affecteds-only linkage methods are not a panacea.

Authors:  D A Greenberg; S E Hodge; V J Vieland; M A Spence
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

2.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

4.  Linkage analysis between schizophrenia and the Darier's disease region on 12q.

Authors:  M P O'Malley; A S Bassett; W G Honer; J L Kennedy; N King; D Berg
Journal:  Psychiatr Genet       Date:  1996       Impact factor: 2.458

5.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

Authors:  R Freedman; H Coon; M Myles-Worsley; A Orr-Urtreger; A Olincy; A Davis; M Polymeropoulos; J Holik; J Hopkins; M Hoff; J Rosenthal; M C Waldo; F Reimherr; P Wender; J Yaw; D A Young; C R Breese; C Adams; D Patterson; L E Adler; L Kruglyak; S Leonard; W Byerley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  New polymorphism for the human serotonin 1D receptor variant (5-HT1D beta) not linked to schizophrenia in five Canadian pedigrees.

Authors:  D G Sidenberg; A S Bassett; L Demchyshyn; H B Niznik; F Macciardi; A B Kamble; W G Honer; J L Kennedy
Journal:  Hum Hered       Date:  1993 Sep-Oct       Impact factor: 0.444

7.  NCAM and schizophrenia: genetic studies.

Authors:  A M Vicente; F Macciardi; M Verga; A S Bassett; W G Honer; G Bean; J L Kennedy
Journal:  Mol Psychiatry       Date:  1997-01       Impact factor: 15.992

8.  Search for unstable DNA in schizophrenia families with evidence for genetic anticipation.

Authors:  A Petronis; A S Bassett; W G Honer; J B Vincent; Y Tatuch; T Sasaki; D J Ying; T A Klempan; J L Kennedy
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

9.  Positive and negative symptoms in families with schizophrenia.

Authors:  A S Bassett; E J Collins; S E Nuttall; W G Honer
Journal:  Schizophr Res       Date:  1993-12       Impact factor: 4.939

10.  Evidence for anticipation in schizophrenia.

Authors:  A S Bassett; W G Honer
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

View more
  14 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.

Authors:  Melissa L Sinkus; Michael J Lee; Judith Gault; Judith Logel; Margaret Short; Robert Freedman; Susan L Christian; Jennifer Lyon; Sherry Leonard
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

Review 3.  High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

Review 4.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

5.  Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type.

Authors:  Laura F Martin; Sherry Leonard; Mei-Hua Hall; Jason R Tregellas; Robert Freedman; Ann Olincy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-07-05       Impact factor: 3.568

Review 6.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

7.  Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15.

Authors:  G Stöber; K Saar; F Rüschendorf; J Meyer; G Nürnberg; S Jatzke; E Franzek; A Reis; K P Lesch; T F Wienker; H Beckmann
Journal:  Am J Hum Genet       Date:  2000-09-19       Impact factor: 11.025

Review 8.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

Review 9.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

10.  Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating.

Authors:  Rachel H Flomen; Madiha Shaikh; Muriel Walshe; Katja Schulze; Mei-Hua Hall; Marco Picchioni; Fruhling Rijsdijk; Timothea Toulopoulou; Eugenia Kravariti; Robin M Murray; Philip Asherson; Andrew J Makoff; Elvira Bramon
Journal:  Eur J Hum Genet       Date:  2012-05-16       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.